Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tbo-filgrastim After Auto HSCT in Multiple Myeloma or Non-Hodgkin Lymphoma
NCT03317899Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Oct 2017
- Primary completion
- Jun 2021
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of filgrastim in neutropenia, sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Oct 2017; status: completed.
02
Drugs
filgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT03317899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03317899.